132 related articles for article (PubMed ID: 9578190)
1. The airway effects of stopping regular oral theophylline in patients with asthma.
Bennett JA; Thompson Coon J; Pavord ID; Wilding PJ; Tattersfield AE
Br J Clin Pharmacol; 1998 Apr; 45(4):402-4. PubMed ID: 9578190
[TBL] [Abstract][Full Text] [Related]
2. Effect of cessation of short-term therapy with ipratropium bromide on lung function and airway responsiveness.
Wilding PJ; Clark MM; Pavord ID; Parker D; Bennett JA; Tattersfield AE
Eur Respir J; 1996 Aug; 9(8):1627-31. PubMed ID: 8866584
[TBL] [Abstract][Full Text] [Related]
3. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
5. Effect of regular terbutaline on the airway response to inhaled budesonide.
Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
[TBL] [Abstract][Full Text] [Related]
6. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
7. The effects of the combination of inhaled ipratropium and oral theophylline in asthma.
Burki NK
Chest; 1997 Jun; 111(6):1509-13. PubMed ID: 9187165
[TBL] [Abstract][Full Text] [Related]
8. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
9. The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5'-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma.
Clarke H; Cushley MJ; Persson CG; Holgate ST
Pulm Pharmacol; 1989; 2(3):147-54. PubMed ID: 2562472
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group.
Schwartz HJ; Petty T; Dubé LM; Swanson LJ; Lancaster JF
Arch Intern Med; 1998 Jan; 158(2):141-8. PubMed ID: 9448552
[TBL] [Abstract][Full Text] [Related]
11. Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline.
Egbagbe E; Pavord ID; Wilding P; Thompson-Coon J; Tattersfield AE
Thorax; 1997 Mar; 52(3):239-43. PubMed ID: 9093339
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
13. Theophylline minimally inhibits bronchoconstriction induced by dry cold air inhalation in asthmatic subjects.
Merland N; Cartier A; L'Archevêque J; Ghezzo H; Malo JL
Am Rev Respir Dis; 1988 Jun; 137(6):1304-8. PubMed ID: 3202370
[TBL] [Abstract][Full Text] [Related]
14. A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
Swystun V; Green FHY; Dennis JH; Rampakakis E; Lalli G; Fadayomi M; Chiu A; Shrestha G; El Shahat SG; Nelson DE; El Mays TY; Pieron CA; Leigh R
Trials; 2018 Jun; 19(1):321. PubMed ID: 29914544
[TBL] [Abstract][Full Text] [Related]
15. Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.
Booth H; Fishwick K; Harkawat R; Devereux G; Hendrick DJ; Walters EH
Thorax; 1993 Nov; 48(11):1121-4. PubMed ID: 8296255
[TBL] [Abstract][Full Text] [Related]
16. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).
Calzetta L; Hanania NA; Dini FL; Goldstein MF; Fairweather WR; Howard WW; Cazzola M
Pulm Pharmacol Ther; 2018 Dec; 53():20-26. PubMed ID: 30219705
[TBL] [Abstract][Full Text] [Related]
17. Effect of theophylline withdrawal on airway inflammation in asthma.
Minoguchi K; Kohno Y; Oda N; Wada K; Miyamoto M; Yokoe T; Hashimoto T; Akabane T; Kobayashi H; Mita S; Kihara N; Adachi M
Clin Exp Allergy; 1998 Aug; 28 Suppl 3():57-63. PubMed ID: 9756188
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of low-dose oral theophylline for treating mild asthma].
Huang SD; Yang J; Zhang SY; Tian LQ; Pan QH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):325-7. PubMed ID: 16546738
[TBL] [Abstract][Full Text] [Related]
19. Long-term xanthine therapy of asthma. Enprofylline and theophylline compared. International Enprofylline Study Group.
Chapman KR; Ljungholm K; Kallen A
Chest; 1994 Nov; 106(5):1407-13. PubMed ID: 7956392
[TBL] [Abstract][Full Text] [Related]
20. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX
Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
